Bone Therapeutics SA of Belgium has appointed Wim Goemaere, formerly of the agro-biotech company Devgen, to the position of chief financial officer. Mr Goemaere was CFO of Devgen when that company was acquired by Syngenta AG in 2012. Prior to that, he was CFO of the Flanders Institute for Biotechnology. Mr Goemaere holds a degree in applied economics from KU Leuven in Belgium.
Bone Therapeutics announced the appointment on 17 September 2013.
Copyright 2013 Evernow Publishing Ltd